DePuy Orthopaedics continues to face a mounting number of legal claims over its recalled ASR hip replacement devices. Most recently, a DePuy ASR hip implant lawsuit was filed by a man who allegedly suffered severe complications shortly after he received the metal-on-metal hip replacement device in 2006. The plaintiff, who is represented by the national law firm of Parker Waichman LLP, filed his suit on July 16 in the DePuy ASR hip implant multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio.
According to the lawsuit, the plaintiff’s ASR hip implant caused him to experience complications such as pain, snapping and popping. The suit alleges that the injuries are a direct result of the defective metal-on-metal hip implant, alleging personal injury, economic loss and loss of services. The lawsuit seeks compensatory and punitive damages for pain and suffering and emotional distress.
The DePuy ASR hip implant is a metal-on-metal hip replacement that was recalled in August 2010, after it was found to be failing within a few years of surgery in an unexpectedly large number of patients. Earlier this week, a study published in the journal, Orthopedics, found that roughly 9% of patients who had undergone revision surgery at two hospitals for failing metal-on-metal hip replacement had been fitted with a DePuy ASR cup.
Metal-on-Metal hip implants have come under increasing scrutiny since the DePuy ASR hip implant recall, amid fears that such devices can shed dangerous amounts of metal ions, which may be absorbed into the bloodstream and local tissue. Complications such as high failure rates, pseudotumors, soft tissue reaction, metallosis and pain have been linked to all-metal hip systems. Last month, the U.S. Food & Drug Administration (FDA) revealed that it had received 16,800 negative event reports involving metal hips between 2000 and 2011. Of those, more than 14,000 involved revision surgeries, in which a defective implant was removed.
Recently, FDA’s Orthopaedic and Rehabilitation Devices Panel recommended that metal-on-metal hip implant patients undergo regular monitoring to ensure their devices are not failing. The panel also called for new warning labels for all-metal hip implants, including warnings regarding their association with the development of pseudotumors and high levels of metal ions in patients’ blood.